Bromantane (Ladasten)
Bromantane (Ladasten) is a unique adamantane derivative and actoprotector developed in the 1980s at the Zakusov State Institute of Pharmacology in Russia, originally field-tested by the Soviet…
View researchBromantane (Ladasten) is a unique adamantane derivative and actoprotector developed in the 1980s at the Zakusov State Institute of Pharmacology in Russia, originally field-tested by the Soviet…
View researchA combination protocol using CJC-1295 without DAC (also known as Mod GRF 1-29) and Ipamorelin through complementary receptor mechanisms.
View researchCJC-1295 with DAC (Drug Affinity Complex) is a modified version of growth hormone releasing hormone (GHRH) engineered for extended duration.
View researchFollistatin 344 (FS-344) is a naturally occurring glycoprotein that inhibits myostatin and activin A, members of the TGF-β superfamily that suppress muscle growth.
View researchHuman Chorionic Gonadotropin (HCG) is a glycoprotein hormone naturally produced by the placenta during pregnancy.
View researchHuman Growth Hormone (HGH), also known as somatropin or somatotropin, is a 191 amino acid single-chain polypeptide hormone naturally produced by the anterior pituitary gland.
View researchIGF-1 LR3 is a synthetic 83-amino acid analog of human insulin-like growth factor-1 that has never been approved for human use in any country.
View researchIpamorelin is a selective growth hormone releasing peptide (GHRP) that stimulates natural growth hormone production from the pituitary gland.
View researchMOTS-c is a 16-amino acid mitochondrial-derived peptide encoded by the mitochondrial genome.
View researchSermorelin acetate is a 29-amino acid synthetic analog of human growth hormone-releasing hormone (GHRH) originally FDA-approved in 1997 for pediatric growth hormone deficiency.
View researchSNAP-8 (Acetyl Octapeptide-3) is a synthetic octapeptide developed as a topical alternative to botulinum toxin for reducing dynamic facial wrinkles.
View researchTB-500 is a synthetic 7-amino acid fragment (Ac-LKKTETQ) corresponding to the active actin-binding region (positions 17-23) of thymosin beta-4.
View research